362 related articles for article (PubMed ID: 35046621)
1. COVID-19 and gut immunomodulation.
Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
Viruses; 2023 May; 15(6):. PubMed ID: 37376531
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
[TBL] [Abstract][Full Text] [Related]
5. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
6. Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
Gutiérrez-Díaz I; Sanz-Martinez M; Castro AM; Rodríguez-Belvís MV; Carreira N; Jiménez S; Mangas C; Queralt M; Herrador M; Martín-Masot R; Ferrer P; Navas-López VM; Espín B; Leis R; Díaz JJ; Delgado S
Eur J Pediatr; 2023 Oct; 182(10):4633-4645. PubMed ID: 37555973
[TBL] [Abstract][Full Text] [Related]
7. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
Grenga L; Pible O; Miotello G; Culotta K; Ruat S; Roncato MA; Gas F; Bellanger L; Claret PG; Dunyach-Remy C; Laureillard D; Sotto A; Lavigne JP; Armengaud J
Environ Microbiol; 2022 Sep; 24(9):4299-4316. PubMed ID: 35506300
[TBL] [Abstract][Full Text] [Related]
8. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
9. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 on the Intestinal Microbiome.
Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-associated diarrhea.
Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
15. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.
Levy E; Stintzi A; Cohen A; Desjardins Y; Marette A; Spahis S
Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G99-G112. PubMed ID: 34009033
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity and COVID-19 - The microbiotal connection.
Katz-Agranov N; Zandman-Goddard G
Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
[TBL] [Abstract][Full Text] [Related]
17. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
19. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
20. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19.
Lai YJ; Chang HS; Yang YP; Lin TW; Lai WY; Lin YY; Chang CC
J Chin Med Assoc; 2021 Sep; 84(9):821-826. PubMed ID: 34282078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]